Creation and study of ready-to-use dosage forms from the stage of synthesis of a medicinal substance to the production of experimental-industrial batches of medicines, including innovative ones;
Expert assessment of the quality of medicinal raw materials and medicinal products made of medicinal plant raw materials;
Provision of services of conducting the quality assessment of hypoglycemic agents (injection forms);
Preclinical studies of a medicine based on a synthetic peptide consisting of D-amino acids and having an immunosuppressive effect, in the form of a powder inhaler;
A methodology for the quantitative determination of medicinal substances and biologically active substances in synthetic and plant-based products has been developed without the use of standard samples.
Research on more than 150 scientific topics has been conducted for pharmaceutical enterprises, the following state contracts have been performed:
1. a service contract for carrying out the expert assessment of the quality of medicinal raw materials and medicinal products made of medicinal plant raw materials;
2. a service contract for carrying out the expert assessment of the quality of hypoglycemic agents (injection forms);
3. “Preclinical studies of a medicinal product based on a synthetic peptide consisting of D-amino acids and having an immunosuppressive effect, in the form of a powder inhaler";
4. “Preclinical studies of a medicinal product based on a synthetic oligopeptide with neurotropic activity to reverse stress-related disorders of the organism in the form of a transbuccal film".
A methodology for the quantitative determination of medicinal substances and biologically active substances in synthetic and plant-based products has been developed without the use of standard samples.
The main achievement is the possibility of performing the work in the Common Use Center (REC) on the creation and study of ready-to-use dosage forms from the stage of the synthesis of a medicinal substance to the production of experimental-industrial batches of medicines, including innovative ones.
The innovative educational programs are developed and adopted in the Center within the framework of additional vocational education (AVE) for advanced training and retraining of specialists in accordance with modern requirements and international standards:
- Pharmaceutical quality assurance;
- Pharmaceutical engineering;
- Quality assurance; training of an authorized officer for pharmaceutical companies;
- Pharmaceutical engineering. Quality assurance for sterile products under GMP conditions.
In 2015 the Center won the competition and concluded the State contract "Development of a complex of educational modules for the implementation of master's programs in the field of study "Chemistry" in the direction (profile) "Instrumental Methods of Pharmacopeia Analysis".